Delaware residents who received their first dose of Covid-19 vaccine 28 or more days ago from any provider and have not yet obtained a second dose may sign up for a Friday appointment at Dover International Speedway’s vaccination event.
The site is operated by the State of Delaware and the Federal Emergency Management Agency.
Those in the new eligibility window should make their appointments for Friday, before 6 p.m. Thursday. According to the Delaware Division of Public Health, this represents a wider eligibility window than the one announced earlier this week.
Those being vaccinated will need to demonstrate with their vaccination card that they received their first dose on or before January 29. Those eligible are individuals who live, work or obtain their health care in Delaware and received their first dose in Delaware.
Many recipients have reported the whole process, including registration, vaccination, and the post-vaccination observation period, taking 30 to 45 minutes.
Scheduling under the new eligibility for these second-dose appointments opened today at de.gov/fema. Those without Internet access may call DPH at 1-833-643-1715, but wait time may be lengthy based on call volume, and online registration should be used if access is available.
Individuals will have an option to create an appointment for someone else after they create their own. However, the appointments are expected to fill quickly, and people may not be able to make family appointments for the same time frame. A single email may be tied to multiple appointments. Everyone who arrives to be vaccinated must have an appointment.
Visitors can drive to the vaccination site via Dover International Speedway’s Leipsic Road entrance. To reduce waiting, those with appointments will be urged not to show up early.
Additional information about COVID-19 vaccine rollout is available at de.gov/covidvaccine. Questions can be directed to the Vaccine Call Center at 1-833-643-1715. People who are deaf or hard of hearing should call 2-1-1 or text their ZIP code to 898-211.
Individuals can email their questions concerning the vaccine to Vaccine@Delaware.gov.
